Armistice Capital’s Creative Medical Technology CELZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-42,000
Closed -$60.9K – 377
2026
Q2
$60.9K Buy
+42,000
New +$90.7K ﹤0.01% 317
2025
Q2
– Sell
-148,000
Closed -$321K – 215
2025
Q1
$321K Buy
+148,000
New +$516K ﹤0.01% 189
2022
Q3
– Sell
-124,418
Closed -$933K – 206
2022
Q2
$933K Buy
+124,418
New +$2.01M 0.02% 128

Other funds holding CELZ

Armistice Capital's CELZ Position: Q3 2026 in Review

Armistice Capital sold out of Creative Medical Technology (CELZ) in Q3 2026, closing a stake of 42,000 shares — an estimated $60.9K sold.

Armistice Capital first reported a position in CELZ in Q2 2022 and held it in 3 quarters. The position peaked at $933K in Q2 2022. 16 funds tracked by Wall St. Rank hold CELZ as of Q3 2026.

  • Armistice Capital reported no remaining Creative Medical Technology position as of Q3 2026 after selling out during the quarter.
  • Armistice Capital sold 42,000 Creative Medical Technology shares in Q3 2026, an estimated $60.9K.
  • Armistice Capital first reported a position in Creative Medical Technology in Q2 2022 and held it in 3 quarters.
  • Armistice Capital's Creative Medical Technology position peaked at $933K in Q2 2022.
  • 16 funds tracked by Wall St. Rank held Creative Medical Technology as of Q3 2026.

Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.